TRACKING DONOR-REACTIVE TCR AS A BIOMARKER IN TRANSPLANTATION

摘要

The invention provides for the use of deep sequencing of the T-cell receptor beta CDR3 to identify, then track donor specific and/or recipient specific T cells in blood, urine and/or end-organs of transplant recipients.